SAPIRSTEIN JAMES - Insider Non-Derivative Transactions at First Wave BioPharma, Inc. (FWBI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 1, 2024, SAPIRSTEIN JAMES's relationship to First Wave BioPharma, Inc. (FWBI) is Director,Officer (Chairman and CEO), and currently has 37,105 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other FWBI insiders.
Data Source: SEC.
SAPIRSTEIN JAMES - Insider Non-Derivative Transactions of FWBI Common Stock
SAPIRSTEIN JAMES - Insider Non-Derivative Transactions at FWBI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 2, 2024 | Sell -- (Common Stock) | 174 | 4.23 | 37105 |
| Mar 16, 2024 | Sell -- (Common Stock) | 1887 | 4.96 | 37279 |
| Jan 13, 2024 | Sell -- (Common Stock) | 166 | 4.2 | 39166 |
| Jan 3, 2024 | Acquisition -- (Common Stock) | 20000 | 0 | 39332 |
| Dec 30, 2023 | Acquisition -- (Common Stock) | 17660 | 0 | 19332 |
| Oct 5, 2023 | Sell -- (Common Stock) | 2764 | 0.29 | 33397 |
| Jul 4, 2023 | Sell -- (Common Stock) | 3349 | 1.54 | 36161 |
| Apr 4, 2023 | Sell -- (Common Stock) | 3347 | 2.5 | 39510 |
| Jan 4, 2023 | Acquisition -- (Common Stock) | 300000 | 0 | 300000 |